Introduction
The Transforming Growth Factor-b (TGF-b) family comprises over 30 members throughout the animal reign that include TGF-bs stricto sensu, Activins and Bone Morphogenic Proteins (BMPs). They are critical in governing cell fate determination and patterning in the developing embryo, and regulate a broad spectrum of biological responses in the adult [1] .
Their pleiotropic activities include context-specific inhibition or stimulation of cell proliferation, control of extracellular matrix (ECM) synthesis and degradation, control of mesenchymal-epithelial interactions during embryogenesis, mediation of cell and tissue responses to injury, and modulation of immune functions. Deregulation of TGF-b signaling has been implicated in developmental disorders and in several human diseases, including cancer, tissue fibrosis, and autoimmune disorders.
Structure and Signaling
The three mammalian TGF-b isoforms, TGF-b1, TGF-b2 and TGF-b3, encoded by three distinct genes, are structurally nearly identical (nine conserved cysteine residues, 76 to 80% amino acid homology), and synthesized by a wide variety of cell types including platelets, protein (CBP) and p300 [3] . Smads also bind transcriptional repressors such as TG-3 interacting factor (TGIF), Ski and SnoN [6] , which modulate the interactions of Smads with the transcriptional activators p300/CBP and recruit histone deacetylases that inhibit gene transcription.
Smad7 binds activated TbRI, thereby preventing phosphorylation of Smad2/3 [7] . It also recruits two ubiquitin-ligases E3 Smurf1 and Smurf2, to the activated TbRI, leading its proteasomal degradation. Smad7 may function as a negative feedback loop, as its expression is induced by TGF-b in a Smad-dependent manner. Finally, several proteins, such as STRAP or YAP-65, stabilize the Smad7-Tb RI association, thereby preventing R-Smad phosphorylation by TbRI and subsequent intracellular signaling [8, 9] .
Aside from the Smads that are highly specific substrates for the TGF-b receptor kinases, other signaling pathways may also be activated by TGF-b in a context-and cell type-specific manner. These include the Mitogen Activated Protein Kinase (MAPK) cascades (p38, ERK and JNK), phosphatidyl-inositol-3-kinase, and PP2A/p70s6K, though the molecular details of such couplings are still obscure. The relative importance and interplay of these various pathways in the changing responses of cells to TGF-b are just beginning to be probed [10, 11] .
Biological functions
Active on all cell types, TGF-b may stimulate or inhibit cell proliferation, differentiation, motility, adhesion or death, depending on the type and developmental state of a cell. These considered a potent anabolic factor that enhances connective tissue deposition and repair [13] .
Of note, TGF-b3, which is mostly expressed during embryonic life, exhibits unique antiscarring properties, as exemplified in knockout animals in which embryonic wound healing is not scarless, as opposed to embryos expressing TGF-b3 [14] .
TGF-b is also critical for maintenance of proper immune functions and knockout mice lacking TGF-b1 die a few weeks after birth from aberrant regulation of the immune response, which culminates in lethal cardiopulmonary inflammation. In this context, TGF-b has been shown to play pivotal role in multiple stages of T cell apoptosis, selection, activation and clearance [15] . would bypass defects in upstream receptors, and thus may serve as chemopreventive agents.
Medical applications
Caution must however be exercised as such approach may accelerate advanced stages of carcinogenesis [10, 17] . Figure 2
